Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatmentmarketing2021-02-15T19:48:14+00:00May 6th, 2020|2020 Publications, Publications| 更多详细信息
Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myelomamarketing2021-02-11T21:50:38+00:00May 1st, 2020|2020 Publications, Publications| 更多详细信息
Primary non-Hodgkin lymphoma of the tongue base: the clinicopathology of seven cases and evaluation of HPV and EBV statusmarketing2021-02-11T21:53:32+00:00April 1st, 2020|2020 Publications, Publications| 更多详细信息
Quantitation of CMV Specific T-Cell Expansion Using T Cell Receptor Beta Locus Deep Sequencing to Identify Patients at Risk of Viral Complicationsmarketing2021-02-11T21:56:18+00:00March 1st, 2020|2020 Publications, Publications| 更多详细信息
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patientsmarketing2021-02-11T21:58:45+00:00February 6th, 2020|2020 Publications, Publications| 更多详细信息
Monitoring minimal residual disease in the bone marrow using next generation sequencingmarketing2021-02-11T22:00:56+00:00January 17th, 2020|2020 Publications, Publications| 更多详细信息